Skip to main content
TipRanks
Go Ultimate75% OFF

InvaGen Pharmaceuticals, Inc. Insider Profile

4 Followers

InvaGen Pharmaceuticals, Inc., Ten Percent Owner at Avenue Therapeutics, holds 0.00 shares in Avenue Therapeutics (Ticker: ATXI). Most recently, InvaGen Pharmaceuticals, Inc. Sold 388,888 shares of Avenue Therapeutics on Oct 13, 2022 for an estimated value of $3.00M.

InvaGen Pharmaceuticals, Inc.'s Trading History

ATXI
Avenue Therapeutics
Oct 13, 2022Ten Percent OwnerInformative Sell3.00M$0.00
ATXI
Insider Shares: 0.00 (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 13, 2022Informative Sell$3.00M388,888$7.71―

You May Also Like

InvaGen Pharmaceuticals, Inc. insider profile FAQ

What stocks does InvaGen Pharmaceuticals, Inc. hold?
InvaGen Pharmaceuticals, Inc. holds: ATXI stocks.
What was InvaGen Pharmaceuticals, Inc.’s latest transaction?
InvaGen Pharmaceuticals, Inc.’s latest transaction was an Informative Sell of $3.00M.
What is InvaGen Pharmaceuticals, Inc.'s role in Avenue Therapeutics?
InvaGen Pharmaceuticals, Inc.'s role in Avenue Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.